Literature DB >> 23562463

The impact of age on the efficacy and safety of catheter ablation for long-standing persistent atrial fibrillation.

Xiao-Dong Zhang1, Jun Gu, Wei-Feng Jiang, Liang Zhao, Yuan-Long Wang, Yu-Gang Liu, Li Zhou, Jia-Ning Gu, Shao-Hui Wu, Kai Xu, Xu Liu.   

Abstract

BACKGROUND: Catheter ablation (CA) has been the most effective treatment for both paroxysmal and persistent atrial fibrillation (AF). However, the impact of age on CA for persistent AF is not well defined.
METHODS: Between January 2010 and August 2011, 258 consecutive patients (85 females, 32.9%), with long-standing persistent AF who underwent CA were prospectively recruited. Age-related differences in clinical presentation, peri-procedural complications, and outcomes were compared.
RESULTS: The study population included 258 patients (85 females, 32.9%): 71 patients in Group I (≤ 55 years), 89 patients in Group II (56-65 years), and 98 patients in Group III (≥ 66 years). Younger patients were more likely to have lone AF (49.3% in Group I, 32.6% in Group II, and 30.6% in Group III; P = 0.029). There was a significant difference in the success rate with advancing age after a single CA (69.0% in Group I, 50.6% in Group II, 40.8% in Group III; P = 0.001). A Cox regression analysis demonstrated age (for each 10 years increase, HR 1.307, CI 1.081-1.580; P = 0.006), sex (HR 1.460, CI 1.017-2.097; P = 0.040) and total AF duration (per year, HR 1.033, CI 1.006-1.060; P = 0.015) as the independent predictors for recurrence after the first CA. However, there was no significant difference in the incidence of peri-procedural complications among the three groups.
CONCLUSIONS: In this consecutive series of patients with long-standing persistent AF, female gender, total AF duration and advanced age were associated with the success of a single CA. The overall rate of complications was similar among all age groups.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Age; Atrial fibrillation; Catheter ablation; Complication; Recurrence

Mesh:

Year:  2013        PMID: 23562463     DOI: 10.1016/j.ijcard.2013.03.025

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  4 in total

Review 1.  Antiarrhythmic therapy of atrial fibrillation: are we treating too late?

Authors:  Kristina Wasmer; Julia Köbe; Lars Eckardt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2014-08-21

Review 2.  Atrial fibrillation and long-term sports practice: epidemiology and mechanisms.

Authors:  S Wernhart; M Halle
Journal:  Clin Res Cardiol       Date:  2014-12-25       Impact factor: 5.460

3.  Influence of Age and Gender on Complications of Catheter Ablation for Atrial Fibrillation.

Authors:  Giuseppe Stabile; Emanuele Bertaglia; Carlo Pappone; Sakis Themistoclakis; Claudio Tondo; Alessandro Zorzi; Matteo Anselmino
Journal:  J Atr Fibrillation       Date:  2015-04-30

4.  Long-term safety and effectiveness of paroxysmal atrial fibrillation ablation using a porous tip contact force-sensing catheter from the SMART SF trial.

Authors:  Andrea Natale; George Monir; Anshul M Patel; Robert S Fishel; Francis E Marchlinski; M Craig Delaughter; Charles A Athill; Daniel P Melby; Mario D Gonzalez; Ramesh Hariharan; Brett Gidney; Tiffany Tan; Larry A Chinitz
Journal:  J Interv Card Electrophysiol       Date:  2020-05-27       Impact factor: 1.900

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.